Mitochondrial Dysfunction and Platelet Hyperactivation: A Novel Therapeutic Target in Sepsis
Sepsis triggers mitochondrial impairment in platelets, promoting hyperactivation via ROS production. The mitochondria-specific antioxidant MitoTEMPO reverses these changes in vitro, suggesting therapeutic potential to prevent sepsis-related organ damage.